세계
보수 성향
Trump's 200% tariff plan may be a bitter pill for US consumers, warns Dr Reddy's
The Times of India
The United States plans significant tariffs on imported generic medicines.
These duties will rise to 200% in the coming years.
Dr Reddy's Laboratories anticipates higher medicine prices for American consumers.
Shifting manufacturing to the US is currently considered impractical by the company.
India faces substantial exposure as a major generic medicine exporter to the US. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
관련 뉴스
25건 · 20개 매체진보 성향 11%중도 성향 58%보수 성향 31%
2개 매체11개 매체6개 매체
관련 뉴스 제보는 로그인 후 가능합니다.
'world' 카테고리 뉴스
The Times of India의 다른 기사
Centre unlikely to sack Pradhan over NEET row, open to compensate for victims' kin: Report
The Times of India
Centre unlikely to sack Pradhan over NEET row, open to compensate victims' kin: Report
The Times of India
'Protect children's future': Centre seeks dialogue with oppn amid protests - top developments
The Times of India